Pay-for-delay laws prohibit settlement agreements in patent cases where generic pharmaceutical companies take payment from a brand pharmaceutical company in exchange for delaying the market launch of their generic drug. In 2019, California became the first state to pass a law banning pay-for-delay settlement agreements. Several other states and the federal government are also considering pay-for-delay legislation. This presentation will discuss the implications of pay-for-delay laws on the pharmaceutical industry.

Pay-for-delay laws may be here to stay

ACS Spring Meeting 2021

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.